Dr. Shijiang Wang 王世江
Chief Physician
Department of Thoracic Radiation Oncology I, Cancer Hospital of Shandong First Medical University (Shandong Cancer Hospital), Jinan
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radiotherapy, chemotherapy, targeted therapy, and immunotherapy for lung, esophageal, and breast cancers. Specializes in precise radiotherapy techniques including IMRT, TOMO, CyberKnife, and proton therapy.
Dr. Wang holds a master’s from Tianjin Medical University and a PhD from Shandong University. Since 2004, Dr. Wang has focused on curative radiotherapy and multidisciplinary care for thoracic tumors. Expertise includes IMRT, TOMO, proton therapy, and combined treatments. Dr. Wang has published over 30 papers and received the China Anti-Cancer Association Science and Technology Progress First Prize.
Professional roles
- Member, Tumor Radiotherapy Professional Committee, China Medical Education Association
- Member, Radiotherapy Branch, Shandong Medical Doctor Association
- Member, Lung Cancer Committee, Shandong Anti-Cancer Association
- Member, Tumor Critical Care Branch, Shandong Anti-Cancer Association
Name order: in Chinese the family name comes first (Wang Shijiang). Papers usually list the name as Shijiang Wang or Wang S.
Selected publications
40 papers on PubMed matched by name and affiliation; 3 as first or senior author since 2016. Most recent first- or senior-author papers:
- Int J Radiat Oncol Biol Phys, 2026 (first author): Prophylactic Recombinant Human Thrombopoietin Prevents Cancer Therapy-Induced Thrombocytopenia During Concurrent Chemoradiation Therapy in Limited-Stage Small Cell Lung Cancer: A Prospective, Multicenter, Phase II Clinical Trial. PubMed 41831791
- Chem Asian J, 2022 (first author): Supramolecular Nanofibers Formed by Enzyme-Instructed Self-Assembly for SKBR-3 Cell Selective Inhibition. PubMed 35510693
- Oncol Lett, 2019 (first author): Effects of respiratory motion on volumetric and positional difference of GTV in lung cancer based on 3DCT and 4DCT scanning. PubMed 30675304
- J Nanobiotechnology, 2015 (senior author): A cell-targeted chemotherapeutic nanomedicine strategy for oral squamous cell carcinoma therapy. PubMed 26427800
- Cell Biochem Biophys, 2015 (first author): Knockdown of PKM2 Enhances Radiosensitivity of Non-small cell Lung Cancer. PubMed 25649613
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion